-
1
-
-
0021256895
-
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebro-vascular amyloid protein
-
Glenner GG and Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebro-vascular amyloid protein. Biochem Biophys Res Commun 120: 885-890, 1984.
-
(1984)
Biochem Biophys Res Commun
, vol.120
, pp. 885-890
-
-
Glenner, G.G.1
Wong, C.W.2
-
2
-
-
0026088977
-
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
-
Goate A, Chartier-Harlin MC, Mullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991.
-
(1991)
Nature
, vol.349
, pp. 704-706
-
-
Goate, A.1
Chartier-Harlin, M.C.2
Mullan, M.3
-
3
-
-
0025925236
-
The 717Val - Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups
-
Yoshioka K, Miki T, Katsuya T, Ogihara T and Sakaki Y: The 717Val - Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. Biochem Biophys Res Commun 178: 1141-1146, 1991.
-
(1991)
Biochem Biophys Res Commun
, vol.178
, pp. 1141-1146
-
-
Yoshioka, K.1
Miki, T.2
Katsuya, T.3
Ogihara, T.4
Sakaki, Y.5
-
4
-
-
0026907151
-
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
-
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B and Lannfelt L: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1: 345-347, 1992.
-
(1992)
Nat Genet
, vol.1
, pp. 345-347
-
-
Mullan, M.1
Crawford, F.2
Axelman, K.3
Houlden, H.4
Lilius, L.5
Winblad, B.6
Lannfelt, L.7
-
5
-
-
0029004341
-
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
-
Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995.
-
(1995)
Nature
, vol.375
, pp. 754-760
-
-
Sherrington, R.1
Rogaev, E.I.2
Liang, Y.3
-
6
-
-
0029101491
-
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
-
Rogaev EI, Sherrington R, Rogaeva EA, et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778, 1995.
-
(1995)
Nature
, vol.376
, pp. 775-778
-
-
Rogaev, E.I.1
Sherrington, R.2
Rogaeva, E.A.3
-
7
-
-
0029087026
-
Candidate gene for the chromosome 1 familial Alzheimer's disease locus
-
Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977, 1995.
-
(1995)
Science
, vol.269
, pp. 973-977
-
-
Levy-Lahad, E.1
Wasco, W.2
Poorkaj, P.3
-
8
-
-
0028587336
-
APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and A beta 1-40) in familial Alzheimer's disease brain
-
Tamaoka A, Odaka A, Ishibashi Y. et al: APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and A beta 1-40) in familial Alzheimer's disease brain. J Biol Chem 269: 32721-32724, 1994.
-
(1994)
J Biol Chem
, vol.269
, pp. 32721-32724
-
-
Tamaoka, A.1
Odaka, A.2
Ishibashi, Y.3
-
9
-
-
16944362157
-
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
-
Citron M, Westaway D, Xia W. et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72, 1997.
-
(1997)
Nat Med
, vol.3
, pp. 67-72
-
-
Citron, M.1
Westaway, D.2
Xia, W.3
-
10
-
-
0028169925
-
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
-
Iwatsubo T, Odaka A, Suzuk Ni, Mizusawa H, Nukina N and Ihara Y: Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45-53, 1994.
-
(1994)
Neuron
, vol.13
, pp. 45-53
-
-
Iwatsubo, T.1
Odaka, A.2
Ni, S.3
Mizusawa, H.4
Nukina, N.5
Ihara, Y.6
-
11
-
-
0038117796
-
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
-
Naslund J, Haroutunian V, Mohs R. Davis KL, Davies P, Greengard P and Buxbaum JD: Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283: 1571-1577, 2000.
-
(2000)
JAMA
, vol.283
, pp. 1571-1577
-
-
Naslund, J.1
Haroutunian, V.2
Mohs, R.3
Davis, K.L.4
Davies, P.5
Greengard, P.6
Buxbaum, J.D.7
-
12
-
-
0033772113
-
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
-
Wolozin B, Kellman W, Ruosseau P, Celesia GG and Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439-1443, 2000.
-
(2000)
Arch Neurol
, vol.57
, pp. 1439-1443
-
-
Wolozin, B.1
Kellman, W.2
Ruosseau, P.3
Celesia, G.G.4
Siegel, G.5
-
13
-
-
0034638746
-
statins and the risk of dementia
-
Jick H, Zornberg GL, Jick SS, Seshadri S and Drachman DA: statins and the risk of dementia. Lancet 356: 1627-1631, 2000.
-
(2000)
Lancet
, vol.356
, pp. 1627-1631
-
-
Jick, H.1
Zornberg, G.L.2
Jick, S.S.3
Seshadri, S.4
Drachman, D.A.5
-
14
-
-
22144453835
-
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD
-
Sparks DL, Sabbagh MN, Connor DJ, et al: Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Curr Alzheimer Res 2: 343-353, 2005.
-
(2005)
Curr Alzheimer Res
, vol.2
, pp. 343-353
-
-
Sparks, D.L.1
Sabbagh, M.N.2
Connor, D.J.3
-
15
-
-
33745739157
-
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
-
Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J and Browne P: Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand Suppl 185: 3-7, 2006.
-
(2006)
Acta Neurol Scand
, Issue.SUPPL. 185
, pp. 3-7
-
-
Sparks, D.L.1
Connor, D.J.2
Sabbagh, M.N.3
Petersen, R.B.4
Lopez, J.5
Browne, P.6
-
16
-
-
0001504829
-
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
-
Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98: 5856-5861, 2001.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5856-5861
-
-
Fassbender, K.1
Simons, M.2
Bergmann, C.3
-
17
-
-
4143063543
-
Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
-
Parvathy S, Ehrlich M, Pedrini S, et al: Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. J Neurochem 90: 1005-1010, 2004.
-
(2004)
J Neurochem
, vol.90
, pp. 1005-1010
-
-
Parvathy, S.1
Ehrlich, M.2
Pedrini, S.3
-
18
-
-
33745109326
-
High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels
-
Thelen KM, Laaksonen R, Paiva H, Lehtimaki T and Lutjohann D: High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol 46: 812-816, 2006.
-
(2006)
J Clin Pharmacol
, vol.46
, pp. 812-816
-
-
Thelen, K.M.1
Laaksonen, R.2
Paiva, H.3
Lehtimaki, T.4
Lutjohann, D.5
-
19
-
-
2442489033
-
Relation of plasma lipids to Alzheimer disease and vascular dementia
-
Reitz C, Tang MX, Luchsinger J and Mayeux R: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61: 705-714, 2004.
-
(2004)
Arch Neurol
, vol.61
, pp. 705-714
-
-
Reitz, C.1
Tang, M.X.2
Luchsinger, J.3
Mayeux, R.4
-
20
-
-
0032836539
-
Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats
-
Yamada K, Tanaka T, Zou LB, et al: Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats. Br J Pharmacol 128: 419-427, 1999.
-
(1999)
Br J Pharmacol
, vol.128
, pp. 419-427
-
-
Yamada, K.1
Tanaka, T.2
Zou, L.B.3
-
21
-
-
0028177692
-
β-amyloid protein-induced Alzheimer's disease animal model
-
Nitta A, Itoh A, Hasegawa T and Nabeshima T: β-amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170: 63-66, 1994.
-
(1994)
Neurosci Lett
, vol.170
, pp. 63-66
-
-
Nitta, A.1
Itoh, A.2
Hasegawa, T.3
Nabeshima, T.4
-
22
-
-
20144387217
-
A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice
-
Tajima H, Kawasumi M, Chiba T, et al: A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 79: 714-723, 2005.
-
(2005)
J Neurosci Res
, vol.79
, pp. 714-723
-
-
Tajima, H.1
Kawasumi, M.2
Chiba, T.3
-
23
-
-
0034521392
-
Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
-
Shibata M, Yamada S, Kumar SR, et al: Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499, 2000.
-
(2000)
J Clin Invest
, vol.106
, pp. 1489-1499
-
-
Shibata, M.1
Yamada, S.2
Kumar, S.R.3
-
24
-
-
0033433983
-
The role of nociceptin in cognition
-
Nabeshima T, Noda Y and Mamiya T: The role of nociceptin in cognition. Brain Res 848: 167-173, 1999.
-
(1999)
Brain Res
, vol.848
, pp. 167-173
-
-
Nabeshima, T.1
Noda, Y.2
Mamiya, T.3
-
25
-
-
0036924890
-
Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction
-
Dayal S, Brown KL, Weydert CJ, et al: Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vase Biol 22: 1996-2002, 2002.
-
(2002)
Arterioscler Thromb Vase Biol
, vol.22
, pp. 1996-2002
-
-
Dayal, S.1
Brown, K.L.2
Weydert, C.J.3
-
26
-
-
0141621234
-
Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays
-
Leissring MA, Lu A, Condron MM, Teplow DB, Stein RL, Farris W and Selkoe DJ: Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays. J Biol Chem 278: 37314-37320, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 37314-37320
-
-
Leissring, M.A.1
Lu, A.2
Condron, M.M.3
Teplow, D.B.4
Stein, R.L.5
Farris, W.6
Selkoe, D.J.7
-
27
-
-
0021137049
-
A highly sensitive fluorometric assay for 'enkephalinase', a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins
-
Florentin D, Sassi A and Roques BP: A highly sensitive fluorometric assay for 'enkephalinase', a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem 141: 62-69, 1984.
-
(1984)
Anal Biochem
, vol.141
, pp. 62-69
-
-
Florentin, D.1
Sassi, A.2
Roques, B.P.3
-
28
-
-
0033621739
-
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
-
Iwata N, Tsubuki S, Takaki Y, et al: Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-150, 2000.
-
(2000)
Nat Med
, vol.6
, pp. 143-150
-
-
Iwata, N.1
Tsubuki, S.2
Takaki, Y.3
-
29
-
-
0346101885
-
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
-
Leissring MA, Farris W, Chang AY, et al: Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093, 2003.
-
(2003)
Neuron
, vol.40
, pp. 1087-1093
-
-
Leissring, M.A.1
Farris, W.2
Chang, A.Y.3
-
30
-
-
0000398342
-
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation
-
Qiu WQ, Walsh DM, Ye Z, et al: Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273: 32730-32738, 1998.
-
(1998)
J Biol Chem
, vol.273
, pp. 32730-32738
-
-
Qiu, W.Q.1
Walsh, D.M.2
Ye, Z.3
-
31
-
-
0034161516
-
Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme
-
Vekrellis K, Ye Z, Qiu WQ, et al: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665, 2000.
-
(2000)
J Neurosci
, vol.20
, pp. 1657-1665
-
-
Vekrellis, K.1
Ye, Z.2
Qiu, W.Q.3
-
32
-
-
0036226252
-
Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35
-
Shen YX, Xu SY, Wei W, Wang, XL Wang H and Sun X: Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35. J Pineal Res 32: 163-167, 2002.
-
(2002)
J Pineal Res
, vol.32
, pp. 163-167
-
-
Shen, Y.X.1
Xu, S.Y.2
Wei, W.3
Wang, X.L.4
Wang, H.5
Sun, X.6
-
33
-
-
1842738222
-
Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo
-
Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Acosta-Martinez JP and Ortiz GG: Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J Neuroimmunol 150: 20-28, 2004.
-
(2004)
J Neuroimmunol
, vol.150
, pp. 20-28
-
-
Rosales-Corral, S.1
Tan, D.X.2
Reiter, R.J.3
Valdivia-Velazquez, M.4
Acosta-Martinez, J.P.5
Ortiz, G.G.6
-
34
-
-
0036449696
-
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice
-
Aliev G, Seyidova D, Neal ML, et al: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 977: 45-64, 2002.
-
(2002)
Ann NY Acad Sci
, vol.977
, pp. 45-64
-
-
Aliev, G.1
Seyidova, D.2
Neal, M.L.3
-
35
-
-
0036468599
-
Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress
-
Yamaguchi Y, Matsuno S, Kagota S, Haginaka J and Kunitomo M: Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress. Eur J Pharmacol 436: 97-105, 2002.
-
(2002)
Eur J Pharmacol
, vol.436
, pp. 97-105
-
-
Yamaguchi, Y.1
Matsuno, S.2
Kagota, S.3
Haginaka, J.4
Kunitomo, M.5
-
36
-
-
7244224783
-
Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis
-
Li Z, Iwai M, Wu L, et al: Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 44: 758-763, 2004.
-
(2004)
Hypertension
, vol.44
, pp. 758-763
-
-
Li, Z.1
Iwai, M.2
Wu, L.3
-
37
-
-
33751398964
-
Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property
-
Matsuki A, Igawa A, Nozawa T, Nakadate T, Igarashi N, Nonomura M and Inoue H: Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property. Circ J 70: 1643-1649, 2006.
-
(2006)
Circ J
, vol.70
, pp. 1643-1649
-
-
Matsuki, A.1
Igawa, A.2
Nozawa, T.3
Nakadate, T.4
Igarashi, N.5
Nonomura, M.6
Inoue, H.7
-
38
-
-
20844454775
-
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants
-
Pat B, Yang T, Kong C, Watters D, Johnson DW and Gobe G: Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67: 931-943, 2005.
-
(2005)
Kidney Int
, vol.67
, pp. 931-943
-
-
Pat, B.1
Yang, T.2
Kong, C.3
Watters, D.4
Johnson, D.W.5
Gobe, G.6
-
39
-
-
0031904324
-
Abnormalities of neural circuitry in Alzheimer's disease: Hippocampus and cortical cholinergic innervation
-
Geula C: Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology 51: S18-S29,1998.
-
(1998)
Neurology
, vol.51
-
-
Geula, C.1
-
40
-
-
8844285984
-
Mouse models of Alzheimer's disease: Insight into treatment
-
German DC and Eisch AJ: Mouse models of Alzheimer's disease: insight into treatment. Rev Neurosci 15: 353-369, 2004.
-
(2004)
Rev Neurosci
, vol.15
, pp. 353-369
-
-
German, D.C.1
Eisch, A.J.2
-
41
-
-
18144419392
-
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study
-
Dufouil C, Richard F, Fievet N, et al: APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 64: 1531-1538, 2005.
-
(2005)
Neurology
, vol.64
, pp. 1531-1538
-
-
Dufouil, C.1
Richard, F.2
Fievet, N.3
-
42
-
-
22844431778
-
Statin use and the risk of incident dementia: The Cardiovascular Health Study
-
Rea TD, Breitner JC, Psaty BM, et al: Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 62: 1047-1051, 2005.
-
(2005)
Arch Neurol
, vol.62
, pp. 1047-1051
-
-
Rea, T.D.1
Breitner, J.C.2
Psaty, B.M.3
-
43
-
-
1842453324
-
Oxidative stress signalling in Alzheimer's disease
-
Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA and Perry G: Oxidative stress signalling in Alzheimer's disease. Brain Res 1000: 32-39, 2004.
-
(2004)
Brain Res
, vol.1000
, pp. 32-39
-
-
Zhu, X.1
Raina, A.K.2
Lee, H.G.3
Casadesus, G.4
Smith, M.A.5
Perry, G.6
-
44
-
-
1242338183
-
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
-
Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC and Mattson MP: Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 101: 2070-2075, 2004.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 2070-2075
-
-
Cutler, R.G.1
Kelly, J.2
Storie, K.3
Pedersen, W.A.4
Tammara, A.5
Hatanpaa, K.6
Troncoso, J.C.7
Mattson, M.P.8
-
45
-
-
19744376800
-
Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients
-
Miwa S, Watada H, Omura C, Takayanagi N, Nishiyama K, Tanaka Y, Onuma T and Kawamori R: Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocr J 52: 259-264, 2005.
-
(2005)
Endocr J
, vol.52
, pp. 259-264
-
-
Miwa, S.1
Watada, H.2
Omura, C.3
Takayanagi, N.4
Nishiyama, K.5
Tanaka, Y.6
Onuma, T.7
Kawamori, R.8
-
46
-
-
33750002577
-
Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms
-
Parsons RB, Price GC, Farrant JK, Subramaniam D, Adeagbo-Sheikh J and Austen BM: Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Biochem J 399: 205-214, 2006.
-
(2006)
Biochem J
, vol.399
, pp. 205-214
-
-
Parsons, R.B.1
Price, G.C.2
Farrant, J.K.3
Subramaniam, D.4
Adeagbo-Sheikh, J.5
Austen, B.M.6
-
47
-
-
13544260853
-
Neurovascular pathways and Alzheimer amyloid beta-peptide
-
Zlokovic BV, Deane R, Sallstrom J, Chow N and Miano JM: Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol 15: 78-83, 2005.
-
(2005)
Brain Pathol
, vol.15
, pp. 78-83
-
-
Zlokovic, B.V.1
Deane, R.2
Sallstrom, J.3
Chow, N.4
Miano, J.M.5
-
48
-
-
0346736491
-
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
-
Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C and Lamas S: Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
-
(1998)
J Clin Invest
, vol.101
, pp. 2711-2719
-
-
Hernandez-Perera, O.1
Perez-Sala, D.2
Navarro-Antolin, J.3
Sanchez-Pascuala, R.4
Hernandez, G.5
Diaz, C.6
Lamas, S.7
-
49
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA and Liao JK: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, T.4
Huang, P.5
Moskowitz, M.A.6
Liao, J.K.7
-
50
-
-
0033048997
-
Attention and executive deficits in Alzheimer's disease. A critical review
-
Perry RJ and Hodges JR: Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122: 383-404, 1999.
-
(1999)
Brain
, vol.122
, pp. 383-404
-
-
Perry, R.J.1
Hodges, J.R.2
-
51
-
-
0034125843
-
On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
-
Bartus RT: On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163: 495-529, 2000.
-
(2000)
Exp Neurol
, vol.163
, pp. 495-529
-
-
Bartus, R.T.1
-
52
-
-
33746041397
-
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice
-
Bellucci A, Luccarini I, Scali C, Prosperi C, Giovannini MG, Pepeu G and Casamenti F: Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis 23: 260-272, 2006.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 260-272
-
-
Bellucci, A.1
Luccarini, I.2
Scali, C.3
Prosperi, C.4
Giovannini, M.G.5
Pepeu, G.6
Casamenti, F.7
|